IMRX

Conviction 4HealthcareScan · Thu, Jun 25, 2026

IMRX$4.53-1.63%

ResistanceSupportVol 14

Vol MA14 1.43M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Immuneering CorpPHARMACEUTICAL PREPARATIONSwww.immuneering.com ↗

Price4.53

Change-1.63%

Gap+1.52%

Rel volume0.97×

Avg volume2.01M

Avg $ vol9.02M

SMA 204.42

SMA 504.99

SMA 2005.77

Price vs 50-9.35%

Price vs 200-21.52%

MA stackbearish

50/200 cross—

Supertrenddown · 5.29

RSI (14)48

MACD hist0.07

MACD crossbull · 4d

Stoch %K / %D71 / 81

ADX (14)15

+DI / −DI26 / 15

RSI divergence—

MACD divergence—

ATR %+7.71%

ADR %8.25%

52w high9.26

52w low3.02

From 52w high-51.13%

Above 52w low+49.83%

New 52w highNo

SqueezeOff

Bollinger width36.79%

%B0.57

Donchian pos33.50%

Donchian high5.85

Donchian low3.86

AVWAP (52w high)5.94

vs AVWAP high-23.86%

AVWAP (52w low)5.79

vs AVWAP low-21.87%

OBV trendDown

Chaikin MF (20)-0.33

Today vs 20d0.97×

Avg vol (14d)1.43M

Avg vol (20d)2.01M

Avg $ vol (20d)9.02M

Market cap117.37M

RS 3m (vs SPY)-24.30%

RS 6m (vs SPY)-26.32%

RS line new highNo

Trend template1/8

Technical rank19.4

1 week+2.61%

1 month-14.14%

3 months-14.94%

6 months-23.43%

1 year+53.91%

YTD-31.65%

P/E-2.10

P/B0.57

P/S—

P/FCF-2.58

EPS-1.27

Div yield—

ROE-27.13%

ROA-26.08%

Debt/Eq—

Current32.45

EV/EBITDA-1.19

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth8.21%

Price target13.75

Target upside203.87%

Analyst ratingBuy

Institutional49.80%

Ent. value70.05M

Revenue0

Net income-13.46M

Gross profit0

Free cash flow-45.49M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out64.7M

Employees55

ListedFri, Jul 30, 2021

Free float36.67M

Float %56.8%

Short interest12.72M

Days to cover5.0d

Short volume45.0%

Squeeze score68 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.21 vs −$0.30

Last surprise+30.0% beat

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank19.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.21

Support3.88

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMRX

All disclosures →

No recent disclosed trades by Congress in IMRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMRX

No recent insider (Form 4) filings in IMRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IMRX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.